SAB Biotherapeutics
SABS
SABS
28 hedge funds and large institutions have $6.78M invested in SAB Biotherapeutics in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 14 increasing their positions, 6 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
73% less capital invested
Capital invested by funds: $25.4M → $6.78M (-$18.7M)
Holders
28
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$175K | |
| 2 | +$144K | |
| 3 | +$133K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$113K |
| 5 |
AWM
AE Wealth Management
Topeka,
Kansas
|
+$70K |
Top Sellers
| 1 | -$6.5M | |
| 2 | -$5.52M | |
| 3 | -$189K | |
| 4 |
VF
Virtu Financial
New York
|
-$120K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$118K |